ARA-290 10MG
$63.00
ARA-290 10MG is a 10-milligram format of ARA-290, an erythropoietin derived peptide analogue designed to model tissue protective signaling without erythropoietic activity. Researchers study ARA-290 in preclinical settings for its potential role in cytoprotection and inflammatory pathway modulation. Studies have also examined it in models involving neuropathic and metabolic stress responses.
In Stock
ARA-290 10MG is a 10-milligram format of ARA-290, an erythropoietin derived peptide analogue developed to engage EPO related tissue protective pathways while avoiding red blood cell stimulating effects associated with full length erythropoietin. In research literature, ARA-290 is also referred to as cibinetide and is typically described as an 11 amino acid peptide modeled from the helix B surface region of erythropoietin.
Researchers study ARA-290 10MG in preclinical models for its potential role in cytoprotection, neuroinflammatory signaling, and small fiber neuropathy related endpoints. Studies have also examined ARA-290 in the context of metabolic stress, pain signaling, and immune cell mediated pathways, with interpretation depending on model design and exposure conditions.
- Specification: 10MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
GHK-Cu 50MG is a 50-milligram format of copper peptide GHK-Cu, a coordination complex formed by the tripeptide glycyl-L-histidyl-L-lysine bound to Cu2+. Researchers study GHK-Cu in models involving skin biology, extracellular matrix signaling, and wound related pathways.
In Stock
NAD 1000MG is a 1000-milligram format of nicotinamide adenine dinucleotide, a ubiquitous pyridine nucleotide cofactor central to cellular redox chemistry. Researchers study NAD in relation to mitochondrial metabolism, energy transfer reactions, and NAD dependent signaling pathways.
In Stock
BPC-157 + GHK-GHK-Cu + KPV 70MG is a 70-milligram combination format featuring BPC-157, a synthetic 15 amino acid peptide, alongside GHK-GHK-Cu, a copper bound GHK repeat peptide complex, and KPV, a tripeptide fragment of alpha MSH. This blend is of interest in peptide research that examines wound environment signaling, extracellular matrix related pathways, and peptide copper interactions. Studies have investigated each component in preclinical models involving connective tissue, skin biology, and inflammatory signaling.
In Stock
Estradiol Cypionate 10mg/ml, 10ml is a specified concentration and volume format of estradiol cypionate, an esterified form of 17 beta estradiol. Researchers use estradiol esters in laboratory work where sustained release profiles are examined in analytical, receptor binding, and pharmacokinetic models.
In Stock
MT1 10Mg 10MG refers to a 10-milligram format of MT1, a melanocortin research peptide commonly associated with melanotropin analog research. Researchers study MT1 in the context of melanocortin receptor signaling, pigmentation pathways, and related neuroendocrine models.
In Stock
CJC-1295 No DAC + Ipamorelin 10MG is a combined 10MG format pairing a CJC 1295 (no DAC) GHRH analogue with ipamorelin, a ghrelin receptor agonist peptide. This blend is commonly used in research that examines pulsatile growth hormone signaling pathways and IGF 1 related biomarkers. Studies have explored these peptides in endocrine and metabolism focused experimental models.
In Stock
CJC 1295 Without DAC 10MG | GHRH 1 29 Peptide Analogue is a 10 mg format of the short GHRH 1 to 29 analogue commonly referred to as Mod GRF 1 to 29. Researchers study this peptide in laboratory work focused on growth hormone signaling models and pulsatile release dynamics. It is frequently used as a reference compound in peptide endocrinology research.
In Stock
BPC-157 + TB-500 – 10MG combines two widely discussed research peptides in a single 10 mg format. BPC-157 is a synthetic 15 amino acid peptide derived from a gastric protective protein fragment, while TB-500 refers to a thymosin beta 4 fragment commonly studied in peptide research. Researchers investigate this pairing in preclinical work involving connective tissue pathways, angiogenesis related signaling, and models of tissue repair and recovery.
In Stock
Testosterone Base – 100mg/ml, 10 is a 100 mg/mL format of testosterone, the primary endogenous androgen and anabolic steroid hormone in humans. Researchers study testosterone in models of androgen receptor signaling, steroidogenesis, and endocrine regulation. It is also used as a reference standard in analytical chemistry and bioassay method development.
In Stock
NAD 500MH refers to a 500MH format of nicotinamide adenine dinucleotide (NAD), a ubiquitous pyridine dinucleotide central to cellular redox chemistry. Researchers study NAD in work involving energy metabolism, mitochondrial function, and enzymatic pathways such as sirtuins and PARPs.
In Stock
BPC-157 + GHK-GHK-Cu + TB-500 70MG is a 70-milligram combination format of three commonly studied research peptides: BPC-157, GHK-Cu, and TB-500. Researchers investigate these peptides in preclinical work involving connective tissue biology, angiogenesis signaling, and recovery related pathways. The blend is used in experimental designs where multiple peptide classes are evaluated together under controlled laboratory conditions.
In Stock
GHK-Cu + TB-500 + BPC-157 + KPV 80MG is an 80-milligram multi-peptide blend combining a copper tripeptide complex with three commonly studied synthetic peptides. Researchers investigate these components in preclinical and in vitro work related to extracellular matrix biology, cell migration signaling, and tissue model recovery. Studies have also examined GHK-Cu, TB-500, BPC-157, and KPV in contexts involving inflammatory signaling pathways and barrier integrity models.
In Stock
